These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 700081)

  • 1. [Effect of amidine and guanidine derivatives on thrombocyte aggregation].
    Lakin KM; Lebid' IN; Gatash SV; Krylov IuF
    Farmakol Toksikol; 1978; 41(5):575-9. PubMed ID: 700081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of aggregation inhibitors on thrombocyte enzymatic activity].
    Lakin KM; Krylov IuF; Nepsha VD
    Farmakol Toksikol; 1978; 41(3):284-8. PubMed ID: 658372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationships between structure and the noradrenaline depleting effects of guanidine and amidine derivatives (author's transl)].
    Benkert B; Benthe HF; Göthert M; Schmoldt A
    Arzneimittelforschung; 1975 Sep; 25(9):1404-8. PubMed ID: 1242662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycyclic N-heterocyclic compounds. Part 62: Reaction of N-(quinazolin-4-yl)amidine derivatives with hydroxylamine hydrochloride and anti-platelet aggregation activity of the products.
    Okuda K; Zhang YX; Ohtomo H; Hirota T; Sasaki K
    Chem Pharm Bull (Tokyo); 2010 Mar; 58(3):369-74. PubMed ID: 20190443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitors of thrombocyte aggregation].
    Lakin KM; Makarov VA; Novikova NV; Tret'iak VM
    Farmakol Toksikol; 1983; 46(3):113-26. PubMed ID: 6134634
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of etmozin on thrombocyte aggregation capacity].
    Dariskiĭ NV; Turilova AI; Korbut R; Marchenkevich E
    Biull Eksp Biol Med; 1982 May; 93(5):74-6. PubMed ID: 6807371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent antimalarial activity of 2-aminopyridinium salts, amidines, and guanidines.
    Calas M; Ouattara M; Piquet G; Ziora Z; Bordat Y; Ancelin ML; Escale R; Vial H
    J Med Chem; 2007 Dec; 50(25):6307-15. PubMed ID: 18004799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of benzamidine derivatives on thrombin-induced platelet reactions.
    Glusa E; Hoffmann A; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):98-106. PubMed ID: 6177615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of xanthine derivatives on thrombocyte aggregation and other hemostatic indices].
    Lakin KM; Ovnatanova MS; Matiashova MA; Mashkovskiĭ MD
    Biull Eksp Biol Med; 1980 Feb; 89(2):181-2. PubMed ID: 7370418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of benzamidine derivatives on platelet function.
    Glusa E; Markwardt F; Hoffmann A
    Acta Univ Carol Med Monogr; 1972; 53():215-9. PubMed ID: 4670730
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental research on the action of isoptin and alkylenediamine derivatives on the aggregation capacity and the membrane-bound calcium level of thrombocytes].
    Mironiuk EP; Manevich EM; Piotrovskiĭ LB; Dumpis MA
    Farmakol Toksikol; 1987; 50(2):42-6. PubMed ID: 3582633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic guanidines: synthesis and antiplatelet activity of 4,6,7,8-tetrahydro-1H-imidazo[1,2-a]pyrazolo[3,4-d]pyrimidin-7-ones and 1,4,6,7,8,9-hexahydropyrazolo [3',4':4,5]pyrimido[2,1-c] [1,2,4]triazin-7-ones.
    Ferroni R; Simoni D; Orlandini P; Bardi A; Franze GP; Guarneri M
    Arzneimittelforschung; 1990 Dec; 40(12):1328-31. PubMed ID: 2095128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors.
    Soyka R; Guth BD; Weisenberger HM; Luger P; Müller TH
    J Med Chem; 1999 Apr; 42(7):1235-49. PubMed ID: 10197967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PAF-antagonists with phospholipid structure. 3. Phospholipids with heterocyclane head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationship].
    Kertscher HP; Ostermann G
    Pharmazie; 1991 Nov; 46(11):772-4. PubMed ID: 1811226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation inhibitors. II - N-heterocyclic aldoxime methiodides (1).
    Antonini I; Franchetti P; Grifantini M; Gulini U; Martelli S; Petrelli F
    Farmaco Sci; 1976 Nov; 31(11):809-16. PubMed ID: 1010032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of biologically active N-methyl derivatives of amidines and cyclized five-membered products of amidines with oxalyl chloride.
    Sondhi SM; Dinodia M; Jain S; Kumar A
    Eur J Med Chem; 2008 Dec; 43(12):2824-30. PubMed ID: 18022734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Derivatives of imidazo[1,2-c]quinazoline with inhibiting effect on platelet aggregation].
    Cardellini M; Franchetti P; Grifantini M; Martelli S; Petrelli F
    Farmaco Sci; 1975 Jul; 30(7):536-46. PubMed ID: 1149881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of trapidil and papaverine on thrombocyte aggregation and phosphodiesterase activity].
    Glusa E
    Farmakol Toksikol; 1986; 49(6):48-9. PubMed ID: 3028860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ADP-induced aggregation of human platelets in diabetes mellitus].
    Chirkov IuIu; Tyshchiuk IA; Severina IS; Starosel'tseva LK
    Vopr Med Khim; 1990; 36(4):20-2. PubMed ID: 2238525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.